Instem plc is a supplier of information technology (IT) applications to the early development healthcare market delivering solutions for data collection, management and analysis across the research and development continuum. The Company is engaged in Global Life Sciences operations. Its lead product suite, Provantis, is an application in the Early Development Safety Assessment (EDSA) market. The Provantis solution incorporates a suite of modules required for managing and recording EDSA studies, from receipt of the compound through to the automated assembly of statistical analyses and final reports. Its software allows scientific staff to collect, analyze and share data across the organization and externally. It also offers ALPHADAS, an early phase clinical software solution. The Company offers Centrus suite, which provides pre-built applications, as well as the ability to utilize a range of business intelligence and analysis tools.
Industry, Sector and Symbol:
- Sector: Technology
- Industry: IT Services & Consulting - NEC
- Sub-Industry: N/A
- Symbol: LON:INS
- CUSIP: N/A
- Web: www.instem.com/
- Market Cap: £30.44 million
- Outstanding Shares: 15,771,000
- 50 Day Moving Avg: GBX 196.60
- 200 Day Moving Avg: GBX 202.02
- 52 Week Range: GBX 171 - GBX 328.55
Sales & Book Value:
- Trailing P/E Ratio: 28.38
- P/E Growth: 0.00
- Annual Revenue: £18.32 million
- Price / Sales: 1.66
- Book Value: GBX 0.81 per share
- Price / Book: 2.38
- EBIDTA: $734,000.00
- Net Margins: 10.76%
- Return on Equity: 16.38%
- Return on Assets: 6.81%
- Average Volume: 7,662 shs.
Frequently Asked Questions for Instem PLC (LON:INS)
What is Instem PLC's stock symbol?
Instem PLC trades on the London Stock Exchange (LON) under the ticker symbol "INS."
Who are some of Instem PLC's key competitors?
Some companies that are related to Instem PLC include Eagle Eye Solutions Group PLC (EYE), Castleton Technology PLC (CTP), NetSol Technologies (NTWK), eGain Corporation (EGAN), eServGlobal Limited (ESG), Watchstone Group PLC (QPP), WidePoint (WYY), Seeing Machines Limited (SEE), ChinaCache International Holdings (CCIH), EG Solutions plc (EGS), Ability (ABIL), Ubisense Group PLC (UBI), Echelon Corporation (ELON), Corero Network Security PLC (CNS), Professional Diversity Network (IPDN), Redstoneconnect PLC (REDS), Tekcapital PLC (TEK) and Cloudbuy PLC (CBUY).
Who are Instem PLC's key executives?
Instem PLC's management team includes the folowing people:
- Philip John Reason, Chief Executive Officer, Executive Director
- Nigel John Goldsmith, Chief Financial Officer, Company Secretary, Executive Director
- MaryBeth Thompson, Chief Operating Officer
- David Gare, Non-Executive Chairman of the Board
- David M. Sherwin, Non-Executive Director
- Michael Frederick McGoun, Non-Executive Independent Director
How do I buy Instem PLC stock?
Shares of Instem PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Instem PLC's stock price today?
MarketBeat Community Rating for Instem PLC (LON INS)MarketBeat's community ratings are surveys of what our community members think about Instem PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Instem PLC stock can currently be purchased for approximately GBX 193.
Consensus Ratings for Instem PLC (LON:INS) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Instem PLC (LON:INS)
(Data available from 7/27/2015 forward)
|9/19/2016||N+1 Singer||Reiterated Rating||Corporate|
Earnings History for Instem PLC (LON:INS)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Instem PLC (LON:INS)
Current Year EPS Consensus Estimate: $2.10 EPS
Dividend History for Instem PLC (LON:INS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Instem PLC (LON:INS)Insider Trades by Quarter for Instem PLC (LON:INS)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
Headline Trends for Instem PLC (LON:INS)
Latest Headlines for Instem PLC (LON:INS)
Instem PLC (INS) Chart for Thursday, July, 27, 2017